Amalgamated Bank Sangamo Therapeutics, Inc Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$0.42 - $1.38 $3,100 - $10,187	-7,382 Reduced 60.23%	4,874 $3,000
Q4 2023 Feb 06, 2024	SELL	$0.3 - $0.63 $435 - $914	-1,451 Reduced 10.59%	12,256 $7,000
Q2 2023 Aug 11, 2023	SELL	$1.11 - $1.74 $987 - $1,548	-890 Reduced 6.1%	13,707 $17,000
Q1 2023 May 02, 2023	SELL	$1.66 - $3.67 $3,691 - $8,162	-2,224 Reduced 13.22%	14,597 $26,000
Q4 2022 Feb 10, 2023	BUY	$2.77 - $5.07 $1,919 - $3,513	693 Added 4.3%	16,821 $53,000
Q3 2022 Nov 09, 2022	BUY	$4.27 - $6.39 $3,582 - $5,361	839 Added 5.49%	16,128 $79,000
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.21 $11,539 - $21,846	-3,518 Reduced 18.71%	15,289 $63,000
Q1 2022 Jun 30, 2022	SELL	$5.23 - $7.82 $8,247 - $12,332	-1,577 Reduced 7.74%	18,807 $109,000
Q4 2021 Feb 15, 2022	SELL	$7.29 - $10.97 $1,530 - $2,303	-210 Reduced 1.02%	20,384 $153,000
Q3 2021 Oct 29, 2021	SELL	$9.01 - $12.01 $9,163 - $12,214	-1,017 Reduced 4.71%	20,594 $186,000
Q2 2021 Aug 16, 2021	BUY	$10.17 - $12.64 $53,361 - $66,322	5,247 Added 32.06%	21,611 $259,000
Q1 2021 May 13, 2021	SELL	$10.88 - $17.05 $17,723 - $27,774	-1,629 Reduced 9.05%	16,364 $205,000
Q4 2020 Feb 12, 2021	BUY	$9.23 - $18.18 $812 - $1,599	88 Added 0.49%	17,993 $280,000
Q3 2020 Oct 30, 2020	SELL	$9.38 - $12.48 $4,239 - $5,640	-452 Reduced 2.46%	17,905 $169,000
Q2 2020 Aug 10, 2020	SELL	$6.21 - $11.83 $8,184 - $15,591	-1,318 Reduced 6.7%	18,357 $164,000
Q1 2020 May 13, 2020	SELL	$5.05 - $8.85 $2,636 - $4,619	-522 Reduced 2.58%	19,675 $125,000
Q4 2019 Feb 13, 2020	BUY	$8.03 - $11.7 $6,560 - $9,558	817 Added 4.22%	20,197 $169,000
Q3 2019 Nov 13, 2019	SELL	$9.05 - $12.22 $1,140 - $1,539	-126 Reduced 0.65%	19,380 $175,000
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $34,632 - $51,572	3,958 Added 25.46%	19,506 $210,000
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $4,238 - $7,032	549 Added 3.66%	15,548 $148,000
Q4 2018 Feb 15, 2019	BUY	$9.51 - $16.6 $142,640 - $248,983	14,999 New	14,999 $172,000
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $201,987 - $294,855	-15,478 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$13.9 - $19.8 $59,686 - $85,021	4,294 Added 38.39%	15,478 $220,000
Q1 2018 May 22, 2018	SELL	$16.7 - $26.35 $4,325 - $6,824	-259 Reduced 2.26%	11,184 $212,000
Q4 2017 Feb 13, 2018	BUY	$11.6 - $17.35 $10,358 - $15,493	893 Added 8.46%	11,443 $188,000
Q3 2017 Nov 09, 2017	BUY	$8.4 - $15.0 $88,620 - $158,250	10,550	10,550 $158,000

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.7M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$23.9 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11.8 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.97 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.78 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.9 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account